German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand
German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand HAMBURG, Germany, May 06, 2021 / B3C newswire / --Richter-Helm BioLogics GmbH & Co. KG, a leading Germany-based, cGMP compliant biopharmaceutical Contract Development and Manufacturing Organization (CDMO) announced today the start of construction for an expansion project at its cGMP manufacturing facility in Bovenau, Germany. The new multi-product biological manufacturing facility is expected to begin full-scale operations and manufacturing by the end of 2023. “The market for pharmaceutical biotech...
Source: pharmiweb.com